Stemcells #39; promising news on spinal cord injury, AMD therapies
Martin McGlynn, CEO of Stemcells Inc., disclosed to BioWorld (http://www.BioWorld.com) fascinating data from a phase I/II clinical trial of human neural stem cells to treat chronic spinal cord...
By:
BioWorld News ViewsView post:
Stemcells' promising news on spinal cord injury, AMD therapies - Video